BRAF and MEK inhibitors change human immune cell phenotype and function; possible consequences for combination therapy

Hoyer S, Eberlein V, Babalija L, Gerer K, Walter L, Schuler G, Schaft N, Heinzerling L, Dörrie J (2018)

Publication Type: Conference contribution

Publication year: 2018

Journal

Experimental Dermatology Wiley

Book Volume: 27

Pages Range: E22-E22

Journal Issue: 3

Authors with CRIS profile

Gerold Schuler Lehrstuhl für Haut- und Geschlechtskrankheiten Niels Schaft Department of Dermatology Lucie Heinzerling Department of Dermatology Jan Dörrie Department of Dermatology

How to cite

APA:

Hoyer, S., Eberlein, V., Babalija, L., Gerer, K., Walter, L., Schuler, G.,... Dörrie, J. (2018). BRAF and MEK inhibitors change human immune cell phenotype and function; possible consequences for combination therapy. (pp. E22-E22).

MLA:

Hoyer, S., et al. "BRAF and MEK inhibitors change human immune cell phenotype and function; possible consequences for combination therapy." 2018. E22-E22.

BibTeX: Download